Tovetumab (Anti-PDGFRA / CD140a)Tovetumab (Anti-PDGFRA / CD140a)
Move your mouse over image or click to enlarge

Tovetumab (Anti-PDGFRA / CD140a)

Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.
Cat# Size Price Qty Buy
A2685-1mg*25 1mg*25
£2,432.00
A2685-1mg*5 1mg*5
£794.00
A2685-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2685

Related Documents